PRLD Competitors & Alternatives

Compare Prelude Therapeutics Inc with similar stocks in the same industry

Biotechnology

PRLD

Main Stock
$4.59
Tradestie Score
49
Market Cap
$85.47M
Revenue Growth
0.4%
Analyst Upside
+74.3%

Top Competitors

237 stocks in Biotechnology
Company Price Market Cap P/E Score Action
DRUG Bright Minds Biosciences Inc. Common Stock
$63.18
$410.79M - 54 Compare
FDMT 4D Molecular Therapeutics, Inc. Common Stock
$13.17
$407.71M - 42 Compare
DSGN Design Therapeutics, Inc. Common Stock
$14.63
$386.68M - 40 Compare
AURA Aura Biosciences, Inc. Common Stock
$7.00
$382.04M - 45 Compare
DRTS Alpha Tau Medical Ltd. Ordinary Shares
$14.43
$371.64M - 53 Compare
CGEM Cullinan Therapeutics, Inc. Common Stock
$20.59
$354.45M - 41 Compare
LBRX LB Pharmaceuticals Inc Common Stock
$44.63
$353.70M - 46 Compare
PROK ProKidney Corp. Class A Ordinary Shares
$1.80
$350.98M - 35 Compare
ALT Altimmune, Inc. Common Stock
$3.27
$341.56M - 36 Compare
ANNX Annexon, Inc. Common Stock
$3.94
$332.96M - 42 Compare

Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)

237 stocks in this industry